Ghasemi A, Jeddi S
EXCLI J. 2023; 22:274-294.
PMID: 36998708
PMC: 10043433.
DOI: 10.17179/excli2022-5720.
Eleazu C, Eleazu K, Chukwuma S, Essien U
J Diabetes Metab Disord. 2013; 12(1):60.
PMID: 24364898
PMC: 7962474.
DOI: 10.1186/2251-6581-12-60.
Lawless M, Norris S, OByrne K, Gray S
J Cell Mol Med. 2009; 13(5):826-52.
PMID: 19175682
PMC: 3823402.
DOI: 10.1111/j.1582-4934.2008.00571.x.
Kernell A, Dahlkvist H, Arnqvist H, Ludvigsson J
Graefes Arch Clin Exp Ophthalmol. 1985; 222(4-5):179-81.
PMID: 15835015
DOI: 10.1007/BF02133669.
Karmarkar D, Rajput C, Wagh S, Kelkar P
Indian J Pediatr. 1993; 60(6):825-7.
PMID: 8200710
DOI: 10.1007/BF02751059.
Protection against streptozotocin-induced diabetes by superoxide dismutase.
Robbins M, Sharp R, Slonim A, Burr I
Diabetologia. 1980; 18(1):55-8.
PMID: 6444904
DOI: 10.1007/BF01228303.
Effect of streptozotocin in a case of glucagon-secreting malignant islets-cell tumor.
Del Prato S, Rovira A, Tessari P, Avogaro A, Nosadini R, Valverde I
J Endocrinol Invest. 1984; 7(2):111-5.
PMID: 6327796
DOI: 10.1007/BF03348399.
Use of pancreatic beta cells in culture to identify diabetogenic N-nitroso compounds.
Wilson G, Mossman B, Craighead J
In Vitro. 1983; 19(1):25-30.
PMID: 6218070
DOI: 10.1007/BF02617990.
Cytotoxic effects of streptozotocin and N-nitrosomethylurea on the pancreatic B cells with special regard to the role of nicotinamide-adenine dinucleotide.
Gunnarsson R, Berne C, HELLERSTROM C
Biochem J. 1974; 140(3):487-94.
PMID: 4374939
PMC: 1168026.
DOI: 10.1042/bj1400487.
Streptozotocin diabetes. Correlation with extent of depression of pancreatic islet nicotinamide adenine dinucleotide.
Anderson T, Schein P, McMenamin M, Cooney D
J Clin Invest. 1974; 54(3):672-7.
PMID: 4369217
PMC: 301601.
DOI: 10.1172/JCI107805.
The synthesis of [14C] streptozotocin and its distribution and excretion in the rat.
Karunanayake E, Hearse D, Mellows G
Biochem J. 1974; 142(3):673-83.
PMID: 4282704
PMC: 1168334.
DOI: 10.1042/bj1420673.
Comparison of streptozotocin and alloxan-induced diabetes in the rat, including volumetric quantitation of the pancreatic islets.
Hoftiezer V, Carpenter A
Diabetologia. 1973; 9(3):178-84.
PMID: 4268550
DOI: 10.1007/BF01219780.
Effect of niacin/nicotinamide deficiency on the diabetogenic effect of streptozotocin.
Wright Jr J, Mendola J, Lacy P
Experientia. 1988; 44(1):38-40.
PMID: 2965027
DOI: 10.1007/BF01960237.
Protective effect of 3-aminobenzamide, an inhibitor of poly (ADP-ribose) synthetase, against streptozotocin-induced diabetes.
Masiello P, Cubeddu T, Frosina G, Bergamini E
Diabetologia. 1985; 28(9):683-6.
PMID: 2933287
DOI: 10.1007/BF00291976.
Effects of very mild versus overt diabetes on vascular haemodynamics and barrier function in rats.
Pugliese G, Tilton R, Speedy A, Chang K, Santarelli E, Province M
Diabetologia. 1989; 32(12):845-57.
PMID: 2533117
DOI: 10.1007/BF00297449.
Effect of nicotinamide treatment on the residual insulin secretion in type 1 (insulin-dependent) diabetic patients.
Vague P, Picq R, Bernal M, Lassmann-Vague V, Vialettes B
Diabetologia. 1989; 32(5):316-21.
PMID: 2526769
DOI: 10.1007/BF00265549.
Macrophage cytotoxicity towards isolated rat islet cells: neither lysis nor its protection by nicotinamide are beta-cell specific.
Kroncke K, Funda J, Berschick B, Kolb H, Kolb-Bachofen V
Diabetologia. 1991; 34(4):232-8.
PMID: 1829693
DOI: 10.1007/BF00405081.
Circadian variation of the streptozotocin-diabetogenic effect in mice.
Candela S, Hernandez R, Gagliardino J
Experientia. 1979; 35(9):1256-7.
PMID: 158539
DOI: 10.1007/BF01963323.
Chronic hypertension induced by streptozotocin in rats.
Kawashima H, Igarashi T, Nakajima Y, Akiyama Y, Usuki K, Ohtake S
Naunyn Schmiedebergs Arch Pharmacol. 1978; 305(2):123-6.
PMID: 153477
DOI: 10.1007/BF00508281.
Nicotinamide and streptozotocin diabetes in the rat. Factors influencing the effectiveness of the protection.
Masiello P, Bergamini E
Experientia. 1977; 33(9):1246-7.
PMID: 142654
DOI: 10.1007/BF01922358.
